These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26957489)

  • 1. A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.
    Vasquez M; Gasparis AP;
    Phlebology; 2017 May; 32(4):272-281. PubMed ID: 26957489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
    Gibson K; Kabnick L;
    Phlebology; 2017 Apr; 32(3):185-193. PubMed ID: 27013511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).
    Todd KL; Wright DI;
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):258-264.e1. PubMed ID: 26992303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized trial of antithrombotic strategies following great saphenous vein ablation using injectable polidocanol endovenous microfoam (Varithena).
    Yang J; Chung S; Srivatsa S
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):488-497.e4. PubMed ID: 36592692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of polidocanol endovenous microfoam in clinical practice.
    Kim PS; Elias S; Gasparis A; Labropoulos N
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):122-127. PubMed ID: 32353594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes.
    Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K;
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of non-compounded polidocanol 1% endovenous microfoam (Varithena) ablation versus endovenous thermal ablation utilizing a systematic review and network meta-analysis.
    Kabnick LS; Jimenez JC; Coogan SM; Gache L; Frame D; Gunnarsson C; Ozsvath K
    J Vasc Surg Venous Lymphat Disord; 2024 Nov; 12(6):101896. PubMed ID: 38679141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with recanalization and reintervention following below knee polidocanol endovenous microfoam ablation for great saphenous and small saphenous veins.
    Fang J; Fang C; Moyal A; Ascher E; Hingorani A; Marks N
    J Vasc Surg Venous Lymphat Disord; 2024 Sep; 12(5):101886. PubMed ID: 38580208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series.
    Davis PE; Phillips J; Kolluri R
    Ann Vasc Surg; 2018 Oct; 52():176-182. PubMed ID: 29772321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of superficial venous insufficiency in a large patient cohort with retrograde administration of ultrasound-guided polidocanol endovenous microfoam versus endovenous laser ablation.
    Deak ST
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):999-1006.e2. PubMed ID: 34958977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
    Jimenez JC; Lawrence PF; Woo K; Chun TT; Farley SM; Rigberg DA; Baril DT; Derubertis BG
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):904-909. PubMed ID: 33248297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency.
    Deak ST
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):477-484. PubMed ID: 29909854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarivein® mechano-chemical ablation an interim analysis of a randomized controlled trial dose-finding study.
    Lam YL; Toonder IM; Wittens CH
    Phlebology; 2016 Apr; 31(3):170-6. PubMed ID: 26249150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
    Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
    J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
    Gonzalez-Zeh R; Armisen R; Barahona S
    J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased body mass index and vein diameter are associated with incomplete target vein closure following microfoam ablation of incompetent saphenous veins.
    Talutis SD; Chin AL; Lawrence PF; Woo K; Farley SM; Duong W; Jimenez JC
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101690. PubMed ID: 37788744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam.
    Lal BK; Mallick R; Wright D
    Phlebology; 2017 Jun; 32(5):342-354. PubMed ID: 28114848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.